Portfolio comparison
Immatics Biotechnologies vs Dephy
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Immatics Biotechnologies
Patents indexed
7
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapyoncologygene_editing
Top Patents7 enriched
US 11407807· 2022
Using Specific Immune Cells to Fight Cancers Like Lung and Breast Cancer
US 10377797· 2019
Training Immune Cells to Fight Cancer Using Specific Markers
US 10314897· 2019
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
Activity by Decade
2010s3
2020s4
Company B
Dephy
Patents indexed
1
Year range
2022
Most recent
2022
consumer_electronicsroboticsmedical_deviceswearable_technologymechanical
Top Patents1 enriched
US 11304827· 2022
Flexible Footplate for Robotic Walking Assistance
Activity by Decade
2020s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.